
Teladoc Abandons the One-Off Virtual Visit
The pioneer of quick-fix telemedicine is admitting that its original business model is no longer enough to survive.
Discover the newest research about AI innovations in 🌐 Telehealth.

The pioneer of quick-fix telemedicine is admitting that its original business model is no longer enough to survive.

The federal lawsuit against Hims & Hers exposes the dangerous friction between rapid telehealth growth and basic consumer privacy.

A year into a massive push to digitize healthcare administration, the tension between voluntary industry promises and hard regulatory mandates is reaching a tipping point.

The rush to digitize GLP-1 prescribing is exposing a dangerous rift between venture-backed growth targets and basic clinical caution.

A new clinical trial shows that AI can guide untrained operators to perform deep vein thrombosis scans, but the real value lies in filtering the patient queue rather than replacing human specialists.

A sudden regulatory shift threatens to dismantle the outsourced remote patient monitoring industry overnight.

Giving patients Bluetooth blood pressure cuffs improves overall health outcomes, but technology alone cannot erase deep-seated racial disparities in clinical care.

A multi-million dollar settlement in California signals a hostile regulatory shift for venture-backed digital health startups nationwide.

A new pilot study suggests heart failure patients can safely adjust their own daily diuretic doses using AI-guided sensor readings, shifting the burden away from overloaded clinical teams.

Health systems are outsourcing the clinical interview to algorithms, but the real test is whether doctors actually regain their time.